We are live on ! Find out more
CALC icon

CalciMedica
CALC

27 hedge funds and large institutions have $14.2M invested in CalciMedica in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $233K | Put options by funds: $44K

4% less funds holding

Funds holding: 28 → 27 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

31% less capital invested

Capital invested by funds: $20.7M → $14.2M (-$6.46M)

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
8
Closed
5
Calls
$233K
Puts
$44K
Net Calls
+$189K
Net Calls Change
+$179K

Top Buyers

1
Bank of New York Mellon
Bank of New York Mellon
New York
+$138K
2
BCM
Bridgeway Capital Management
Texas
+$49K
3
Renaissance Technologies
Renaissance Technologies
New York
+$33.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$32.4K
5
Osaic Holdings
Osaic Holdings
Arizona
+$25.8K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$319K
2
SC
Sculptor Capital
New York
-$240K
3
GCP
GSA Capital Partners
United Kingdom
-$158K
4
Two Sigma Investments
Two Sigma Investments
New York
-$57.6K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$6.5M – – –
O
2
OrbiMed
New York
$5.12M – – –
Osaic Holdings
3
Osaic Holdings
Arizona
$740K +$25.8K +1,357 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$561K +$32.4K +1,703 +6%
First Manhattan
5
First Manhattan
New York
$359K – – –
Morgan Stanley
6
Morgan Stanley
New York
$198K -$319K -16,721 -59%
BCM
7
Bridgeway Capital Management
Texas
$155K +$49K +2,571 +40%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$125K +$138K +7,260 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$70K – – –
Two Sigma Investments
10
Two Sigma Investments
New York
$63K -$57.6K -3,022 -45%
Citadel Advisors
11
Citadel Advisors
Florida
$63K -$10.4K -548 -13%
JJ
12
Johnson & Johnson
New Jersey
$61K – – –
State Street
13
State Street
Massachusetts
$43K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$43K +$33.1K +1,738 +221%
BlackRock
15
BlackRock
New York
$40K -$2.11K -111 -5%
Brown Advisory
16
Brown Advisory
Maryland
$25K +$8.48K +445 +45%
Northern Trust
17
Northern Trust
Illinois
$20K – – –
UBS Group
18
UBS Group
Switzerland
$9K +$6.06K +318 +149%
Group One Trading
19
Group One Trading
Illinois
$3K -$3.68K -193 -52%
Federated Hermes
20
Federated Hermes
Pennsylvania
$3K +$1.75K +92 +159%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$1K -$19 -1 -2%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$1K – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$1K +$724 +38 New
SC
24
Sculptor Capital
New York
– -$240K -9,350 Closed
GCP
25
GSA Capital Partners
United Kingdom
– -$158K -6,157 Closed
1
2

CALC Hedge Fund Activity: Q1 2022 in Review

27 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q1 2022, worth a combined $14.2M — down 31% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CALC and 4 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 6 added.

The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $138K. The largest seller was Morgan Stanley, cutting an estimated $319K.

  • 27 institutional investors held CalciMedica (CALC) as of Q1 2022, down from 28 in Q4 2021.
  • Funds reported $14.2M of CalciMedica stock for Q1 2022, down 31% quarter-over-quarter.
  • 4 funds opened new CalciMedica positions in Q1 2022 and 5 closed out, a net change of -1 holder.
  • The largest CalciMedica buyer in Q1 2022 was Bank of New York Mellon, an estimated $138K added.
  • The largest CalciMedica seller in Q1 2022 was Morgan Stanley, an estimated $319K sold.

Based on aggregated 13F filings for Q1 2022.